Evidence map›Paper›PMID 27877013›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2016

The association of

Qing Sun, Xuedan Guo, Qi Wang, Fan Zhao

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Synergism of Adipocytokine Profile andCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qing SunDepartment of Oncology, Wuxi 2nd People's Hospital, Affiliated to Nanjing Medical University, Wuxi 214002, China.
Xuedan GuoDepartment of Oncology, Wuxi 2nd People's Hospital, Affiliated to Nanjing Medical University, Wuxi 214002, China.
Qi WangDepartment of Oncology, Wuxi 2nd People's Hospital, Affiliated to Nanjing Medical University, Wuxi 214002, China.
Fan ZhaoDepartment of Oncology, Wuxi 2nd People's Hospital, Affiliated to Nanjing Medical University, Wuxi 214002, China.
Wuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMany studies have examined the association between the

methodsThe PubMed and CNKI (China National Knowledge Infrastructure) database was searched for case-control studies. Odds ratios (OR) with 95% CIs were used to determine the strength of association between the

resultsUltimately, 21 studies, comprising 2,923 hepatocellular carcinoma cases and 4,323 controls were included. Overall, the A carriers (G/A + A/A)

conclusionsThe

Indexed as

hepatocellular carcinomapolymorphismsusceptibilityTNF-308

Identifiers

PMID27877013
PMCPMC5101228
OpenAlexW1801796080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.